NCT00191360已完成3 期
Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 68
- 试验地点
- 14
- 主要终点
- Long-term safety of growth hormone replacement in adult patients with growth hormone deficiency
研究概览
简要总结
To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Having completed the preceding long-term study of growth hormone replacement in adult patients diagnosed with growth hormone deficiency.
- •Other pituitary hormone deficiencies being replaced if appropriate
排除标准
- •With severe impairments of cardiac, pulmonary, renal or hepatic functions
- •With severe psychological disorders
- •With malignant cancer
- •With hypertension uncontrolled
- •With diabetes mellitus
结局指标
主要结局
Long-term safety of growth hormone replacement in adult patients with growth hormone deficiency
次要结局
- Maintenance of efficacy of growth hormone replacement, measured by lean body mass, which is achieved in the previous trial in adult patients wtih growth hormone deficiency
研究者
研究点 (14)
Loading locations...
相似试验
招募中
不适用
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in ChildrenGrowth Hormone DeficiencyIdiopathic Short StatureSmall for Gestational AgeChronic Renal FailureTurner SyndromeNCT01604395LG Chem6,000
已完成
2 期
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart FailureGrowth Hormone DeficiencyChronic Heart FailureNCT01576861Federico II University28
已完成
3 期
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature SecondaryGrowth Hormone DeficiencyGrowth RetardationNCT00174278Pfizer14
已完成
不适用
Metabolic Endocrinology and Growth Hormone in AdultsAdult Growth Hormone DeficiencyNCT01080755Merck KGaA, Darmstadt, Germany90
已完成
2 期
Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).Growth Hormone DeficiencyNCT00778518Ambrx, Inc.36